Description
Fladrafinil [Tablets]
Fladrafinil is a synthetic eugeroic compound, also known by the chemical name CRL-40 941. It belongs to the same compound family as Adrafinil and Modafinil, researched for their potential effect on wakefulness and cognition in laboratory models.
In laboratory settings, Fladrafinil tablets are formulated to promote wakefulness and alertness in experimental models. The tablet formulation contains microcrystalline cellulose, magnesium stearate, silica (silicon dioxide), and lactose. In addition, Fladrafinil tablet formulation ensures accurate dosage and proper disintegration for consistent research results.
Chemical Properties
| Product Name | Fladrafinil |
| CAS | 90212-80-9 |
| Molar Mass | 325.3 g/mol |
| Chemical Formula | C15H13F2NO3S |
| IUPAC Name | 2-[bis(4-fluorophenyl)methylsulfinyl]-N-hydroxyacetamide |
| Synonyms | CRL-40,941, Fluorafinil, Bisfluoroadrafinil |
Working Mechanism of Fladrafinil [Tablets]
The working mechanism of Fladrafinil is primarily centered on how compounds interact with the central nervous system (CNS) to influence different pathways. Let’s explore the mechanism:
-
Effects on neurotransmitter system
In laboratory settings, Fladrafinil is observed to potentially influence the dopamine and norepinephrine signaling. Both transmitters are associated with motivation and alertness in laboratory models.
It is hypothesized to slightly inhibit dopamine reuptake, Fladrafinil allows more dopamine to remain active in the synaptic space. This may support focus and alertness with comparatively lower stimulation in models like typical stimulants (e.g., amphetamines).
-
May Support wakefulness
Fladrafinil may support hypothalamus pathways associated with wakefulness. It is the part of the brain that controls arousal and sleep. As a result the experimental models may show alertness and mental clarity, even in the conditions of reduced circadian rhythm.
-
May influence cognitive performance
In experimental settings, the compound indirectly enhances prefrontal cortex activity, which governs decision-making, planning, and attention. By balancing neurotransmitter activity, it may help in reducing mental fatigue and improving sustained cognitive performance in laboratory models.
In addition, it is suggested that it may influence glutamate and GABA signaling, contributing to mental stability and focus. This may support alertness without overstimulation or hyperactivity.
-
May have slower metabolic conversion
In laboratory settings, Fladrafinil is observed to balance emotional reactivity and may affect serotonin-related pathways, although evidence is limited. This characteristic rendered it of interest in research into behavioral control and mental calmness under stress or fatigue.
What Are the Potential Benefits of Fladrafinil Tablets?
In laboratory settings the compound may have the following benefits:
- Reduce sense of fatigue
- Improve cognitive performance
- May support emotional regulation in experimental models
- May improve reaction time in experimental models
What Are the Potential Side Effects of Fladrafinil Tablets?
In experimental settings the tablet formulation may have following side effects:
- Headaches
- Restlessness
- Fatigue
- Loss of appetite
- Nausea
Why Buy the Fladrafinil Tablets From RCDbio?
RCDbio provides high-quality tablet formulations for laboratory research purposes only. RCDbio aims to be your trusted online source for research-grade synthetic compounds.
All our products are supported with a Certificate of Analysis (COA). In addition, we provide a quick and secure transaction experience to our buyers.
FAQs
What is the shelf life of Fladrafinil tablets?
The shelf life of Fladrafinil tablets is typically 2–3 years when stored under recommended conditions.
What are the optimal storage conditions?
It is recommended to store in a cool and dry place at 20°C – 25°C (68°F – 77°F). Keep protected from direct sunlight and moisture exposure.
Can Fladrafinil tablets be dissolved in solution?
Yes, it may be solubilized in ethanol, DMSO, or suitable buffer solutions for laboratory research.
Are Fladrafinil tablets approved for medical use?
No, Fladrafinil tablets are not yet approved by the FDA and are only available for laboratory research purposes. So, these tablet formulations remain an investigational research chemical.
Disclaimer
Fladrafinil tablets are intended exclusively for laboratory research purposes. RCDbio products are not intended to diagnose, treat, cure, or prevent any disease.
The Food and Drug Administration has not evaluated the statements on our website. Researchers must comply with all applicable local laws and regulations. By purchasing, you agree to our Terms and Conditions.
For queries, complaints, or support, please contact support@rcdbio.co.
Reviews
There are no reviews yet